India Diabetes Care Devices Investment Opportunities

Analysis and Forecasts to 2012

Product Code GMD07488
Publication Date September 2008
Publisher Global Markets Direct
Product Type Report
Pages 142
ISBN Number not applicable
Change currency
PDF £1,895.00 €2,282 $2,996 BUY >
Order by fax
Ask a question about this product > Receive product alerts > Call now +44 20 7060 7474

India Diabetes Care Devices Investment Opportunities

Analysis and Forecasts to 2012

This report is an essential source for in-depth information and data relating to the India diabetes care devices market. It also offers detailed and comprehensive coverage of market revenue, volume, distribution and company share information; and latest news, financial deals and pipeline products information of each of the key sub-segments of the diabetes care devices in India

Scope

  • The report provides diabetes care devices information broken down into detailed categories and segments in India.
  • Total revenues, products sold, end users, and average pricing.
  • Market shares of all the key competitors.
  • Key pipeline products that are set to shape the market, broken down by sector.
  • Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis, and financial information.
  • Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
  • Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
  • Key mergers and acquisitions, partnerships, private equity investments and IPOs.
  • Customer, hospitals and physicians data.

Reasons to buy

  • Gain a strong understanding of the diabetes care devices market in India.
  • Evaluate and compare the attractiveness of the market in the country.
  • Identify growth segments and opportunities in each industry sector within the country.
  • Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the country.
  • Analyze the competitiveness of the market in the country and identify hotspots.
  • Develop strategies based on the latest product, brand, expansion and research and development news in the country.
  • Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the country.
  • Identify and analyze the strengths and weaknesses of the industry incumbents in the country.

Contents

  • 1 List of Tables
    • 1.2 List of Figures
  • 2 Introduction
    • 2.1 What Is This Report About?
    • 2.2 Definitions
      • 2.2.1 Diabetes Care Devices
        • 2.2.1.1 Glucose Monitoring
        • 2.2.1.2 Insulin Delivery
  • 3 Healthcare Sector Review
    • 3.1 Healthcare Expenditure
    • 3.2 Healthcare Infrastructure
      • 3.2.1 Healthcare Personnel in India
    • 3.3 Healthcare Policy
  • 4 Diabetes Care Devices in India
    • 4.1 Diabetes Care Devices Overall Revenues (2000-2012)
    • 4.2 Diabetes Care Devices Overall Volume (2000-2012)
    • 4.3 Diabetes Care Devices Overall Company Share (2005-2006)
  • 5 Glucose Monitoring in India
    • 5.1 Glucose Monitoring Overall Revenues (2000-2012)
      • 5.1.1 Blood Glucose Test Strips Overall Revenues (2000-2012)
      • 5.1.2 Blood Glucose Meters Overall Revenues (2000-2012)
    • 5.2 Glucose Monitoring Overall Volume (2000-2012)
      • 5.2.1 Blood Glucose Test Strips Overall Volumes (2000-2012)
      • 5.2.2 Blood Glucose Meters Overall Volumes (2000-2012)
    • 5.3 Glucose Monitoring Average Price (2000-2012)
      • 5.3.1 Blood Glucose Test Strips Average Price (2000-2012)
      • 5.3.2 Blood Glucose Meters Average Price (2000-2012)
    • 5.4 Glucose Monitoring Distribution Share (2005-2006)
    • 5.5 Glucose Monitoring Company Share (2005-2006)
  • 6 Insulin Delivery in India
    • 6.1 Insulin Delivery Overall Revenues (2000-2012)
      • 6.1.1 Insulin Syringes Overall Revenues (2000-2012)
      • 6.1.2 Insulin Pumps Overall Revenues (2000-2012)
      • 6.1.3 Insulin Pens Overall Revenues (2000-2012)
    • 6.2 Insulin Delivery Overall Volume (2000-2012)
      • 6.2.1 Insulin Syringes Overall Volume (2000-2012)
      • 6.2.2 Insulin Pumps Overall Volume (2000-2012)
      • 6.2.3 Insulin Pens Overall Volume (2000-2012)
    • 6.3 Insulin Delivery Average Price (2000-2012)
      • 6.3.1 Insulin Syringes Average Price (2000-2012)
      • 6.3.2 Insulin Pumps Average Price (2000-2012)
      • 6.3.3 Insulin Pens Average Price (2000-2012)
    • 6.4 Insulin Delivery Distribution Share (2005-2006)
    • 6.5 Insulin Delivery Company Share (2005-2006)
  • 7 Overview of key Companies
    • 7.1 F. Hoffmann-La Roche Ltd
      • 7.1.1 F. Hoffmann-La Roche Ltd Company Overview
      • 7.1.2 F. Hoffmann-La Roche Ltd Business Overview
        • 7.1.2.1 Products
        • 7.1.2.2 History
        • 7.1.2.3 Location and Subsidiaries
      • 7.1.3 F. Hoffmann-La Roche Ltd Financial Overview
      • 7.1.4 F. Hoffmann-La Roche Ltd SWOT Analysis
      • 7.1.5 F. Hoffmann-La Roche Ltd Value Chain Analysis
    • 7.2 Novo Nordisk A/S
      • 7.2.1 Novo Nordisk A/S Company Overview
      • 7.2.2 Novo Nordisk A/S Business Overview
        • 7.2.2.1 Products
        • 7.2.2.2 History
        • 7.2.2.3 Location and Subsidiaries
    • 7.3 LifeScan, Inc
      • 7.3.1 LifeScan, Inc. Company Overview
      • 7.3.2 LifeScan, Inc. Business Overview
        • 7.3.2.1 Products
        • 7.3.2.2 History
        • 7.3.2.3 Location and Subsidiaries
    • 7.4 Abbott Laboratories
      • 7.4.1 Abbott Laboratories Company Overview
      • 7.4.2 Abbott Laboratories Business Overview
        • 7.4.2.1 Products
        • 7.4.2.2 History
        • 7.4.2.3 Location and Subsidiaries
      • 7.4.3 Abbot laboratories Financial Overview
      • 7.4.4 Abbott laboratories SWOT Analysis
      • 7.4.5 Abbott Laboratories Value Chain Analysis
    • 7.5 Bayer HealthCare AG
      • 7.5.1 Bayer HealthCare AG Company Overview
      • 7.5.2 Bayer HealthCare AG Business Overview
        • 7.5.2.1 History
        • 7.5.2.2 Location and Subsidiaries
      • 7.5.3 Bayer HealthCare AG SWOT Analysis
      • 7.5.4 Bayer HealthCare AG Value Chain Analysis
  • 8 Regulation System
    • 8.1 Medical Equipment Approval
    • 8.2 Central Drugs Authority of India (CDAI)
    • 8.3 Medical Device Regulatory Authority of India (MDRAI)
    • 8.4 Classification of Medical Devices
      • 8.4.1 Registration Period
  • 9 Pricing and Reimbursement
    • 9.1 Pricing and Reimbursement
  • 10 Distribution Structure
    • 10.1 Distribution Structure
  • 11 Financial Deals Landscape
    • 11.1 Partnership
      • 11.1.1 Nicholas Piramal India And ARKRAY Forms ARKRAY PIRAMAL Medical
  • 12 Recent Developments
    • 12.1 Government and Public Interest
      • 12.1.1 Jul 18, 2008: Drug-Eluting Stents Enters Into Indian Market
  • 13 Appendix
    • 13.1 Methodology
    • 13.2 Currency Conversion
    • 13.3 Contact Us
    • 13.4 Disclaimer
  • 1 List of Tables
    • Table 1: Healthcare Personnel by Specialty in India, 2000-2007
    • Table 2: Diabetes Care Devices, India, Overall Revenues ($ mn), 2000-2012
    • Table 3: Diabetes Care Devices, India, Overall Revenues ($ mn), Historic, 2000-2007
    • Table 4: Diabetes Care Devices, India, Overall Revenues ($ mn), Forecast, 2007-2012
    • Table 5: Diabetes Care Devices, India, Category Revenues ($ mn), 2000-2012
    • Table 6: Diabetes Care Devices, India, Category Revenues ($ mn), Historic, 2000-2007
    • Table 7: Diabetes Care Devices, India, Category Revenues ($ mn), Forecast, 2007-2012
    • Table 8: Diabetes Care Devices, India, Category Volume (Units), 2000-2012
    • Table 9: Diabetes Care Devices, India, Category Volume (Units), Historic, 2000-2007
    • Table 10: Diabetes Care Devices, India, Category Volume (Units), Forecast, 2007-2012
    • Table 11: Diabetes Care Devices, India, Overall Company Share by Revenue ($ mn) 2005-2006
    • Table 12: Glucose Monitoring, India, Overall Revenues ($ mn), Historic, 2000-2007
    • Table 13: Glucose Monitoring, India, Overall Revenues ($ mn), Forecast, 2007-2012
    • Table 14: Glucose Monitoring, India, Revenue by segment ($ mn), Historic 2000-2007
    • Table 15: Glucose Monitoring, India, Revenue by segment ($ mn), forecast 2007-2012
    • Table 16: Blood Glucose Test Strips, India, Overall Revenues ($ mn), Historic, 2000-2007
    • Table 17: Blood Glucose Test Strips, India, Overall Revenues ($ mn), Forecast, 2007-2012
    • Table 18: Blood Glucose Meters, India, Overall Revenues ($ mn), Historic, 2000-2007
    • Table 19: Blood Glucose Meters, India, Overall Revenues ($ mn), Forecast, 2007-2012
    • Table 20: Glucose Monitoring, India, Overall Volume (Units), Historic, 2000-2007
    • Table 21: Glucose Monitoring, India, Overall Volume (Units), Forecast, 2007-2012
    • Table 22: Blood Glucose Test Strips, India, Overall Volume (Units), Historic, 2000-2007
    • Table 23: Blood Glucose Test Strips, India, Overall Volume (Units), Forecast, 2007-2012
    • Table 24: Blood Glucose Meters, India, Overall Volume (Units), Historic, 2000-2007
    • Table 25: Blood Glucose Meters, India, Overall Volume (Units), Forecast, 2007-2012
    • Table 26: Blood Glucose Test Strips, India, Average Price ($), Historic, 2000-2007
    • Table 27: Blood Glucose Test Strips, India, Average Price ($), Forecast, 2007-2012
    • Table 28: Blood Glucose Meters, India, Average Price ($), Historic, 2000-2007
    • Table 29: Blood Glucose Meters, India, Average Price ($), Forecast, 2007-2012
    • Table 30: Glucose Monitoring, India, Distribution Share by Revenue , 2005-2006
    • Table 31: Glucose Monitoring, India, Company Share by Revenue , 2005-2006
    • Table 32: Insulin Delivery , India, Overall Revenues ($ mn), Historic, 2000-2007
    • Table 33: Insulin Delivery , India, Overall Revenues ($ mn), Forecast, 2007-2012
    • Table 34: Insulin Delivery, India, Revenue by segment ($ mn), Historic, 2000-2007
    • Table 35: Insulin Delivery, India, Revenue by segment ($ mn), Forecast, 2007-2012
    • Table 36: Insulin Syringes, India, Overall Revenues ($ mn), Historic, 2000-2007
    • Table 37: Insulin Syringes, India, Overall Revenues ($ mn), Forecast, 2007-2012
    • Table 38: Insulin Pumps, India, Overall Revenues ($ mn), Historic, 2000-2007
    • Table 39: Insulin Pumps, India, Overall Revenues ($ mn), Forecast, 2007-2012
    • Table 40: Insulin Pens, India, Overall Revenues ($ mn), Historic, 2000-2007
    • Table 41: Insulin Pens, India, Overall Revenues ($ mn), Forecast, 2007-2012
    • Table 42: Insulin Delivery , India, Overall Volume (Units), Historic, 2000-2007
    • Table 43: Insulin Delivery , India, Overall Volume (Units), Forecast, 2007-2012
    • Table 44: Insulin Syringes, India, Overall Volume (Units), Historic, 2000-2007
    • Table 45: Insulin Syringes, India, Overall Volume (Units), Forecast, 2007-2012
    • Table 46: Insulin Pumps, India, Overall Volume (Units), Historic, 2000-2007
    • Table 47: Insulin Pumps, India, Overall Volume (Units), Forecast, 2007-2012
    • Table 48: Insulin Pens, India, Overall Volume (Units), Historic, 2000-2007
    • Table 49: Insulin Pens, India, Overall Volume (Units), Forecast, 2007-2012
    • Table 50: Insulin Syringes, India, Average Price ($), Historic, 2000-2007
    • Table 51: Insulin Syringes, India, Average Price ($), Forecast, 2007-2012
    • Table 52: Insulin Pumps, India, Average Price ($), Historic, 2000-2007
    • Table 53: Insulin Pumps, India, Average Price ($), Forecast, 2007-2012
    • Table 54: Insulin Pens, India, Average Price ($), Historic, 2000-2007
    • Table 55: Insulin Pens, India, Average Price ($), Forecast, 2007-2012
    • Table 56: Insulin Delivery , India, Distribution Share by Revenue , 2005-2006
    • Table 57: Insulin Delivery , India, Company Share by Revenue , 2005-2006
    • Table 58: F. Hoffmann-La Roche Ltd. Financial and Operational Overview, 2006-2002
    • Table 59: F. Hoffmann-La Roche Ltd. Financial and Operational Overview, 2006-2002
    • Table 60: Abbott Laboratories Financial and Operational Overview, 2006-2002
    • Table 61: Abbott Laboratories Financial and Operational Overview, 2006-2002
    • Table 62: Currency Conversion from USD to Local Currency at 2007 Constant Rate
    • 1.2 List of Figures
    • Figure 1: Total Healthcare Expenditure in India, 2000-2006
    • Figure 2: Healthcare Expenditure in India by Source, 2006
    • Figure 3: Diabetes Care Devices, India, Overall Revenues ($ mn), 2000-2012
    • Figure 4: Diabetes Care Devices, India, Overall Revenues ($ mn), Historic, 2000-2007
    • Figure 5: Diabetes Care Devices, India, Overall Revenues ($ mn), Forecast, 2007-2012
    • Figure 6: Diabetes Care Devices, India, Category Revenues ($ mn), 2000-2012
    • Figure 7: Diabetes Care Devices, India, Category Revenues ($ mn), Historic, 2000-2007
    • Figure 8: Diabetes Care Devices, India, Category Revenues ($ mn), Forecast, 2007-2012
    • Figure 9: Diabetes Care Devices, India, Category Volume (Units), Historic, 2000-2007
    • Figure 10: Diabetes Care Devices, India, Category Volume (Units), Forecast, 2007-2012
    • Figure 11: Diabetes Care Devices, India, Overall Company Share (%) 2005-2006
    • Figure 12: Glucose Monitoring, India, Overall Revenues ($ mn), Historic, 2000-2007
    • Figure 13: Glucose Monitoring, India, Overall Revenues ($ mn), Forecast, 2007-2012
    • Figure 14: Glucose Monitoring, India, Revenue by segment ($ mn), Historic 2000-2007
    • Figure 15: Glucose Monitoring, India, Revenue by segment ($ mn), forecast 2007-2012
    • Figure 16: Blood Glucose Test Strips, India, Overall Revenues ($ mn), Historic, 2000-2007
    • Figure 17: Blood Glucose Test Strips, India, Overall Revenues ($ mn), Forecast, 2007-2012
    • Figure 18: Blood Glucose Meters, India, Overall Revenues ($ mn), Historic, 2000-2007
    • Figure 19: Blood Glucose Meters, India, Overall Revenues ($ mn), Forecast, 2007-2012
    • Figure 20: Blood Glucose Test Strips, India, Overall Volume (Units), Historic, 2000-2007
    • Figure 21: Blood Glucose Test Strips, India, Overall Volume (Units), Forecast, 2007-2012
    • Figure 22: Blood Glucose Meters, India, Overall Volume (Units), Historic, 2000-2007
    • Figure 23: Blood Glucose Meters, India, Overall Volume (Units), Forecast, 2007-2012
    • Figure 24: Blood Glucose Meters, India, Average Price ($), Historic, 2000-2007
    • Figure 25: Blood Glucose Meters, India, Average Price ($), Forecast, 2007-2012
    • Figure 26: Glucose Monitoring, India, Distribution Share (%), 2006
    • Figure 27: Glucose Monitoring, India, Company Share (%), 2006
    • Figure 28: Insulin Delivery , India, Overall Revenues ($ mn), Historic, 2000-2007
    • Figure 29: Insulin Delivery , India, Overall Revenues ($ mn), Forecast, 2007-2012
    • Figure 30: Insulin Delivery, India, Revenue by segment ($ mn), Historic, 2000-2007
    • Figure 31: Insulin Delivery, India, Revenue by segment ($ mn), Forecast, 2007-2012
    • Figure 32: Insulin Syringes, India, Overall Revenues ($ mn), Historic, 2000-2007
    • Figure 33: Insulin Syringes, India, Overall Revenues ($ mn), Forecast, 2007-2012
    • Figure 34: Insulin Pumps, India, Overall Revenues ($ mn), Historic, 2000-2007
    • Figure 35: Insulin Pumps, India, Overall Revenues ($ mn), Forecast, 2007-2012
    • Figure 36: Insulin Pens, India, Overall Revenues ($ mn), Historic, 2000-2007
    • Figure 37: Insulin Pens, India, Overall Revenues ($ mn), Forecast, 2007-2012
    • Figure 38: Insulin Syringes, India, Overall Volume (Units), Historic, 2000-2007
    • Figure 39: Insulin Syringes, India, Overall Volume (Units), Forecast, 2007-2012
    • Figure 40: Insulin Pumps, India, Overall Volume (Units), Historic, 2000-2007
    • Figure 41: Insulin Pumps, India, Overall Volume (Units), Forecast, 2007-2012
    • Figure 42: Insulin Pens, India, Overall Volume (Units), Historic, 2000-2007
    • Figure 43: Insulin Pens, India, Overall Volume (Units), Forecast, 2007-2012
    • Figure 44: Insulin Pumps, India, Average Price ($), Historic, 2000-2007
    • Figure 45: Insulin Pumps, India, Average Price ($), Forecast, 2007-2012
    • Figure 46: Insulin Pens, India, Average Price ($), Historic, 2000-2007
    • Figure 47: Insulin Pens, India, Average Price ($), Forecast, 2007-2012
    • Figure 48: Insulin Delivery , India, Distribution Share (%), 2006
    • Figure 49: Insulin Delivery , India, Company Share (%), 2006
    • Figure 50: Proposed Medical Equipment Classification in India, 2005